Home » Topics » BioWorld Science

BioWorld Science
RSS

IL-4 and IL-13 drive atopic dermatitis pathology by regulating sex steroid hormone synthesis

Oct. 4, 2021

French researchers patent BTNL8-binding antibodies for IBD

Oct. 4, 2021

Jinan University describes new tyrosine protein kinase inhibitors for cancer

Oct. 4, 2021

Marvel Biotechnology identified new adenosine A2A receptor antagonists

Oct. 4, 2021

Suzhou Zanrong Pharma discloses HER2 inhibitors

Oct. 4, 2021

Medshine Discovery patents new BCL2/BCL2L1 inhibitors

Oct. 4, 2021

Discovery of novel potent and selective IRAK1 degraders

Oct. 4, 2021

Elastase inhibition enhances the adjuvant activity of alum for SARS-CoV-2 vaccination

Oct. 1, 2021

Different way of looking allows new insights into cancer biology

Oct. 1, 2021

Antibodies targeting glycosylated CD44 synthesized at Go Therapeutics

Oct. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...